BRPI0401888A - Forma de aplicação oral para etilésteres de ácido 3-[(2-{[4- (hexiloxicarbonilamino-imino-metil)-fenilamino]-meti l}-1-metil-1h-benzimidazol-5-carbonil)-piridin-2-il-amin o]-propiÈnico e seus sais - Google Patents

Forma de aplicação oral para etilésteres de ácido 3-[(2-{[4- (hexiloxicarbonilamino-imino-metil)-fenilamino]-meti l}-1-metil-1h-benzimidazol-5-carbonil)-piridin-2-il-amin o]-propiÈnico e seus sais

Info

Publication number
BRPI0401888A
BRPI0401888A BRPI0401888A BRPI0401888A BR PI0401888 A BRPI0401888 A BR PI0401888A BR PI0401888 A BRPI0401888 A BR PI0401888A BR PI0401888 A BRPI0401888 A BR PI0401888A
Authority
BR
Brazil
Prior art keywords
methyl
benzimidazol
amino
carbonyl
salts
Prior art date
Application number
Other languages
English (en)
Inventor
Ulrich Brauns
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Priority to BRPI0401888 priority Critical patent/BRPI0401888A/pt
Publication of BRPI0401888A publication Critical patent/BRPI0401888A/pt

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"FORMA DE APLICAçãO ORAL PARA ETILéSTERES DE áCIDO 3-¢(2-{¢4-(HEXILOXICARBONILAMINO-IMINO-METIL)-FENILAMIN O!-METIL)-1-METIL-lH-BENZIMIDAZOL-5-CARBONIL)-PIRIDIN2-I L-AMINO!-PROPIÈNICO E SEUS SAIS". A presente invenção refere-se a uma nova forma de aplicação oral a ser aplicada para a substância ativa etiléster de ácido 3-¢(2-{¢4-(hexiloxicarbonilamino-imino-metil)-fenilaminolmetil}-1 -metil-1 H-benzimidazol-5-carbonil)-piridin-2-il-amino!-propiónico e seus sais farmaceuticamente compatíveis.
BRPI0401888 2004-06-01 2004-06-01 Forma de aplicação oral para etilésteres de ácido 3-[(2-{[4- (hexiloxicarbonilamino-imino-metil)-fenilamino]-meti l}-1-metil-1h-benzimidazol-5-carbonil)-piridin-2-il-amin o]-propiÈnico e seus sais BRPI0401888A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0401888 BRPI0401888A (pt) 2004-06-01 2004-06-01 Forma de aplicação oral para etilésteres de ácido 3-[(2-{[4- (hexiloxicarbonilamino-imino-metil)-fenilamino]-meti l}-1-metil-1h-benzimidazol-5-carbonil)-piridin-2-il-amin o]-propiÈnico e seus sais

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0401888 BRPI0401888A (pt) 2004-06-01 2004-06-01 Forma de aplicação oral para etilésteres de ácido 3-[(2-{[4- (hexiloxicarbonilamino-imino-metil)-fenilamino]-meti l}-1-metil-1h-benzimidazol-5-carbonil)-piridin-2-il-amin o]-propiÈnico e seus sais

Publications (1)

Publication Number Publication Date
BRPI0401888A true BRPI0401888A (pt) 2006-01-17

Family

ID=35550999

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0401888 BRPI0401888A (pt) 2004-06-01 2004-06-01 Forma de aplicação oral para etilésteres de ácido 3-[(2-{[4- (hexiloxicarbonilamino-imino-metil)-fenilamino]-meti l}-1-metil-1h-benzimidazol-5-carbonil)-piridin-2-il-amin o]-propiÈnico e seus sais

Country Status (1)

Country Link
BR (1) BRPI0401888A (pt)

Similar Documents

Publication Publication Date Title
BR0306559A (pt) Forma de aplicação oral para etilésteres de ácido 3-[(2-{[4-(hexiloxicarbonilamino-imino-metil)-fenilamin o]-metil}-1-metil-1h-ben-zimidazol-5-carbonil)-piridin- 2-il-amino]-propiÈnico e seus sais
MY145632A (en) 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethylester-methanesulfonate and its use as a medicament
TW200509996A (en) Tablet containing 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethylester or the salts thereof
GEP20115302B (en) Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5- trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
WO2008068615A8 (en) Crystalline forms of ( 3 s ) -3- [n- (n' - (2-tert-butylphenyl) oxamyl) alaninyl] amino-5- (2 ', 3 ', 5 ', 6 ' -tetrafluoro phenoxy) -4-0x0penta noic acid
IL198979A (en) Enzyme inhibitors diacylglycerol o-acetyltransferase type 1
EP2234963A4 (en) LEVODOPA FORMULATIONS WITH CONTROLLED RELEASE AND ITS USE
AR104566A2 (es) Forma cristalina de la sal diclorhidrato de ((1s)-1-(((2s)-2-(5-(4-(2-((2s)-1-((2s)-2-((metoxicarbonil)amino)-3-metilbutanoil)-2-pirrolidinil)-1h-imidazol-5-il)-4-bifenilil)-1h-imidazol-2-il)-1-pirrolidinil)carbonil)-2-metilpropil)carbamato de metilo
DOP2010000391A (es) Composicion y proceso-356
WO2006036936A3 (en) The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
ATE499088T1 (de) Glp-1-fc fusionsprotein-formulierung
BR112012008317A2 (pt) produto de liberação sustentada compreendendo uma combinação de uma amina não-opioide e uma droga anti-inflamatória não-esteroidal
BRPI0906104A2 (pt) "derivado de ácido nuclêico peptídico, composição farmacêutica contendo uma quantidade "terapeuticamente eficaz do derivado de ácido nuclêico peptídico, composição farmacêutica contendo uma quantidade terapeuticamente eficaz do derivado de ácido nuclêico peptídico,método de utilização do derivado de ácido nuclêico peptídico e composto"
ATE540041T1 (de) Prodrug-salze von 2,4-pyrimidindiaminverbindungen und anwendungen davon
UY30136A1 (es) Sal especifica, forma anhidra y cristalina de un derivado de dihidropteridiona
AR051003A1 (es) Forma cristalina de un compuesto bifenilo
WO2006037047A3 (en) The r-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
NO20073854L (no) Doseringsform og fremgangsmate for vedvarende frigjoring av en substituert pyrazinforbindelse
BR0307071A (pt) ésteres hidroxamato do ácido n-(fenil 4-substituìdo)-antranìlico
UA97660C2 (ru) Жидкие композиции солей 4-[2-(4-метилфенилсульфанил)фенил]-пиперидина
NO20083836L (no) N-hydroksyakrylamidforbindelser
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
MY163501A (en) Anti-biofilm carbonate compouns for use in oral care compositions
NO20085317L (no) Imidazoazepinonforbindelser
PE20061394A1 (es) Metabolitos de n-(2-cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil]-2-metil-4-pirimidinil]amino]-5-tiazolcarboxamidas

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B03H Publication of an application: rectification [chapter 3.8 patent gazette]

Free format text: REFERENTE A RPI 1828 DE 17/01/2006, QUANTO AO ITEM (72); CONFORME SOLICITADO NA PETICAO NO047409/ RJ DE 19/08/2004.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]